In a big breakthrough for Brisbane-based Ellume, the Biden administration has struck a $US230 million ($302 million) deal for the Australian diagnostic specialist’s rapid COVID-19 home tests.
The White House announced the deal on Monday (Tuesday AEDT) saying it would drive mass production and slash the cost of quick tests, seen as a critical way to reopen large parts of America’s battered economy.
Loading...
Jacob Greber writes about politics, economics and business from Canberra. He has been a Washington correspondent and economics correspondent. Connect with Jacob on Twitter. Email Jacob at jgreber@afr.com
